Literature DB >> 32221694

Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia.

Cigdem Sahbaz1, Noushin Zibandey2, Ayse Kurtulmus3, Yazgul Duran2, Muazzez Gokalp2, Ismet Kırpınar3, Fikrettin Sahin4, Sinan Guloksuz5,6, Tunc Akkoc2.   

Abstract

AIM: To investigate whether circulating T cells including regulatory T cells (Treg) and derived cytokines contribute to the immune imbalance observed in schizophrenia.
METHODS: Forty patients with schizophrenia and 40 age, sex, body mass index, education, and smoking status-matched healthy controls (HC) are included in the study. We stained cells with anti-CD14, anti-CD3, anti-CD4, anti-CD8, anti-CD19, anti-CD20, and anti-CD16/56. Peripheral blood mononuclear cells (PBMCs) were isolated and stained with the human FoxP3 kit containing anti-CD4/anti-CD25 and intracellular anti-Foxp3. PBMCs were cultured for 72 h and stimulated with anti-CD3/anti-CD28. Cytokines (IL-2, IL-4, IL-6, IL-10, IFN-γ, TNF-α, and IL-17A) were measured from the culture supernatant and plasma using the Th1/Th2/Th17 cytokine bead array kit.
RESULTS: In comparison with HC, Treg percentages in schizophrenia were higher (1.17 ± 0.63 vs 0.81 ± 0.53, P = 0.005) in unstimulated but lower in the stimulated condition (0.73 ± 0.69 vs 0.97 ± 0.55, P = 0.011). Activated T cell percentages were higher in schizophrenia than HC in unstimulated (2.22 ± 0.78 vs 1.64 ± 0.89, P = 0.001) and stimulated (2.25 ± 1.01 vs 1.72 ± 1.00, P = 0.010) conditions. The culture supernatant levels of IL-6 (7505.17 ± 5170.07 vs 1787.81 ± 1363.32, P < 0.001), IL-17A (191.73 ± 212.49 vs 46.43 ± 23.99, P < 0.001), TNF-α (1557 ± 1059.69 vs 426.57 ± 174.62, P = 0.023), and IFN-γ (3204.13 ± 1397.06 vs 447.79 ± 270.13, P < 0.001); and plasma levels of IL-6 (3.83 ± 3.41vs 1.89 ± 1.14, P = 0.003) and IL-17A (1.20 ± 0.84 vs 0.83 ± 0.53, P = 0.033) were higher in patients with schizophrenia than HC.
CONCLUSION: Our explorative study shows reduced level of Foxp3 expressing Treg in a stimulated condition with induced levels of proinflammatory cytokines in patients with schizophrenia.

Entities:  

Keywords:  Adaptive immunity; FoxP3; IL-17A; Regulatory T cell; Schizophrenia; T cell

Mesh:

Substances:

Year:  2020        PMID: 32221694     DOI: 10.1007/s00213-020-05504-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects.

Authors:  Marco Cosentino; Marco Ferrari; Natasa Kustrimovic; Emanuela Rasini; Franca Marino
Journal:  Hum Immunol       Date:  2015-09-30       Impact factor: 2.850

2.  Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia.

Authors:  Nikola A Bowden; Judith Weidenhofer; Rodney J Scott; Ulrich Schall; Juanita Todd; Patricia T Michie; Paul A Tooney
Journal:  Schizophr Res       Date:  2006-01-18       Impact factor: 4.939

Review 3.  Psychosis: an autoimmune disease?

Authors:  Adam A J Al-Diwani; Thomas A Pollak; Sarosh R Irani; Belinda R Lennox
Journal:  Immunology       Date:  2017-08-03       Impact factor: 7.397

4.  The NF-κB signaling pathway: an important therapeutic target in psychiatric disorders.

Authors:  M A Altinoz; B Ince; C Tek; V H Srihari; S Guloksuz
Journal:  Mol Psychiatry       Date:  2016-11-15       Impact factor: 15.992

5.  Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.

Authors:  Milica Borovcanin; Ivan Jovanovic; Gordana Radosavljevic; Slavica Djukic Dejanovic; Dragic Bankovic; Nebojsa Arsenijevic; Miodrag L Lukic
Journal:  J Psychiatr Res       Date:  2012-09-10       Impact factor: 4.791

6.  Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study.

Authors:  Michael E Benros; Philip R Nielsen; Merete Nordentoft; William W Eaton; Susanne O Dalton; Preben B Mortensen
Journal:  Am J Psychiatry       Date:  2011-12       Impact factor: 18.112

Review 7.  Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

Authors:  Monojit Debnath; Michael Berk
Journal:  Schizophr Bull       Date:  2014-04-07       Impact factor: 9.306

8.  Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway.

Authors:  Dimitre H Dimitrov; Shuko Lee; Jesse Yantis; Celina Valdez; R Madelaine Paredes; Nicole Braida; Dawn Velligan; Consuelo Walss-Bass
Journal:  Schizophr Res       Date:  2013-11-05       Impact factor: 4.939

9.  Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder.

Authors:  Carine Hartmann do Prado; Lucas Bortolotto Rizzo; Andréa Wieck; Rodrigo Pestana Lopes; Antonio L Teixeira; Rodrigo Grassi-Oliveira; Moisés Evandro Bauer
Journal:  Psychoneuroendocrinology       Date:  2012-09-16       Impact factor: 4.905

10.  Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms.

Authors:  Rachel M Craddock; Helen E Lockstone; David A Rider; Matthew T Wayland; Laura J W Harris; Peter J McKenna; Sabine Bahn
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

View more
  8 in total

Review 1.  Schizophrenia and Alarmins.

Authors:  Huan Ma; Ning Cheng; Caiyi Zhang
Journal:  Medicina (Kaunas)       Date:  2022-05-24       Impact factor: 2.948

Review 2.  Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner.

Authors:  Wenbin Liu; Meiyang Fan; Wen Lu; Wenhua Zhu; Liesu Meng; Shemin Lu
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 3.  Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

Authors:  Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg
Journal:  Behav Brain Res       Date:  2021-01-14       Impact factor: 3.332

4.  Comprehensive DNA Methylation Analysis of Human Neuroblastoma Cells Treated With Haloperidol and Risperidone.

Authors:  Jianbin Du; Yutaka Nakachi; Tomoki Kiyono; Shinya Fujii; Kiyoto Kasai; Miki Bundo; Kazuya Iwamoto
Journal:  Front Mol Neurosci       Date:  2021-12-06       Impact factor: 5.639

5.  Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls.

Authors:  Rudolf Engelke; Sami Ouanes; Suhaila Ghuloum; Rifka Chamali; Nancy Kiwan; Hina Sarwath; Frank Schmidt; Karsten Suhre; Hassen Al-Amin
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 4.157

6.  Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia.

Authors:  Aleksandra Koricanac; Aleksandra Tomic Lucic; Mirjana Veselinovic; Danijela Bazic Sretenovic; Gorica Bucic; Anja Azanjac; Olivera Radmanovic; Mirjana Matovic; Marijana Stanojevic; Aleksandra Jurisic Skevin; Bojana Simovic Markovic; Jelena Pantic; Nebojša Arsenijevic; Gordana D Radosavljevic; Maja Nikolic; Nenad Zornic; Jelena Nesic; Nemanja Muric; Branimir Radmanovic
Journal:  Front Psychiatry       Date:  2022-07-25       Impact factor: 5.435

7.  Schizophrenia Hypothesis: Autonomic Nervous System Dysregulation of Fetal and Adult Immune Tolerance.

Authors:  Tamara Carnac
Journal:  Front Syst Neurosci       Date:  2022-07-01

8.  Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition.

Authors:  Slavica Minic Janicijevic; Ivan P Jovanovic; Nevena M Gajovic; Milena M Jurisevic; Monojit Debnath; Nebojsa N Arsenijevic; Milica M Borovcanin
Journal:  World J Psychiatry       Date:  2022-09-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.